Testing the waters

Pediatric Critical Care Medicine

Volumn 8, Issue 3, 2007, Pages 305-307

  Zimmerman, Jerry J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal insufficiency; Children; Corticotropin stimulation test; Cortisol; Evidence based medicine; Free cortisol; Gluconeogenesis; Hydrocortisone; Hyperglycemia; Sepsis

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; METHYLPREDNISOLONE;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; EDITORIAL; ENDOCRINOLOGY; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH SURVEY; HUMAN; INTENSIVE CARE; LABORATORY TEST; MORTALITY; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; SAFETY; SEPSIS; SEPTIC SHOCK; WATER ANALYSIS;

ADRENAL INSUFFICIENCY; CHILD; EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS, PEDIATRIC; SEPSIS;

EID: 34248356738     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000262882.51753.D3     Document Type: Editorial

References (46)

1. Sprung CL, Caralis PV, Marcial EH, et al: The effects of high-dose corticosteroids in patients with septic shock: A prospective, controlled study. N Engl J Med 1984; 311:1137-1143
2. Bone RC, Fisher CJ Jr, Clemmer TP, et al: Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987; 92:1032-1036
3. The Veterans Administration Systemic Sepsis Cooperative Study Group: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317:659-665
4. Menon K, Lawson, M: Identification of adrenal insufficiency in pediatric critical illness. Pediatr Crit Care Med 2007; 8:276-278
5. Hildebrandt T, Mansour M, Al Samsam R: The use of steroids in children with septicemia: Review of the literature and assessment of current practice in PICUs in the UK. Paediatr Anaesth 2005; 15:358-365
6. Czaja A, Zimmerman J: Endpoints/treatment algorithms for RCTs of steroids in pediatric sepsis. Abstr. Crit Care Med 2004; 32:A127
7. Riordan FA, Thomson AP, Ratcliffe JM, et al: Admission cortisol and adrenocorticotrophic hormone levels in children with meningo-coccal disease: Evidence of adrenal insufficiency? Crit Care Med 1999; 27:2257-2261
8. Auletta JJ, O'Riordan MA, Nieder ML: Infections in children with cancer: A continued need for the comprehensive physical examination. J Pediatr Hematol Oncol 1999; 21:501-508
9. Hatherill M, Tibby SM, Hilliard T, et al: Adrenal insufficiency in septic shock. Arch Dis Child 1999; 80:51-55
10. Van Woensel JB, Biezeveld MH, Alders AM, et al: Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease. J Infect Dis 2001; 184:1532-1537
11. De Kleijn ED, Joosten KF, Van Rijn B, et al: Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 2002; 21:330-336
12. Joosten KF, de Kleijn ED, Westerterp M, et al: Endocrine and metabolic responses in children with meningococcal sepsis: Striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 2000; 85:3746-3753
13. Pizarro CF, Troster EJ, Damiani D, et al: Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med 2005; 33:855-859
14. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
15. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
16. Yildiz O, Doganay M, Aygen B, et al: Physiological-dose steroid therapy in sepsis. Crit Care 2002; 6:251-259
17. Keh D, Boehnke T, Weber-Cartens S, et al: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167:512-520
18. Oppert M, Schindler R, Husung C, et al: Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33:2457-2464
19. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
20. Annane D: Corticosteroids for patients with septic shock. JAMA 2003; 289:43-44
21. Annane D: Etomidate and intensive care physicians. Intensive Care Med 2005; 31:1454
22. Den Brinker M, Joosten KF, Liem O, et al: Adrenal insufficiency in meningococcal sepsis: Bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005; 90:5110-5117
23. Hadassah Medical Organization European Society of Intensive Care Medicine, International Sepsis Forum, The Gorham Foundation: Corticosteroid therapy of septic shock-corticus. Online at: clinicaltrials. gov. Accessed February 15, 2007
24. Palencia E: Hidrocortisona en el shock séptico: Primeros resultados del CORTICUS. Revista Electronica de Medicina Intensiva 2006; 6:A43
25. Min MUT, Aye M, Shwe TN, et al: Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health 1975; 6:573-579
26. Sumarmo, Talogo W, Asrin A, et al: Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982; 69:45-49
27. Slusher T, Gbadero D, Howard C, et al: Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis. Pediatr Infect Dis J 1996; 15:579-583
28. Annane D: Cortisol replacement for severe sepsis and septic shock: What should I do? Crit Care 2002; 6:190-191
29. Celkan T, Ozkan A, Apak H, et al: Bacteremia in childhood cancer. J Trop Pediatr 2002; 48:373-377
30. Annane D, Briegel J, Keh D, et al: Clinical equipoise remains for issues of adrenocorticotropic hormone administration, cortisol testing, and therapeutic use of hydrocortisone. Crit Care Med 2003; 31:2250-2251
31. Bakker J, Grover R, McLuckie A, et al: Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study. Crit Care Med 2004; 32:1-12
32. Watson D, Grover R, Anzueto A, et al: Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, doubleblind, placebo-controlled multicenter study. Crit Care Med 2004; 32:13-20
33. Lopez A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30
34. Annane D: Replacement therapy with hydrocortisone in catecholamine- dependent septic shock. J Endotoxin Res 2001; 7:305-309
35. Annane D, Bellissant E, Sebille V, et al: Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998; 46:589-597
36. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
37. Faustino EV, Apkon M: Persistent hyperglycemia in critically ill children. J Pediatr 2005; 146:30-34
38. Srinivasan V, Spinella PC, Drott HR, et al: Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004; 5:329-336
39. Van den Berghe G: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195
40. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
41. Van den Berghe GH: Role of intravenous insulin therapy in critically ill patients. Endocr Pract 2004; 10(Suppl 2):17-20
42. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145
43. Sarthi MLR, Vivekananhan S, Arora N: Adrenal status in children with septic shock using low dose stimulation test. Pediatr Crit Care Med 2007; 8:23-28
44. Annane D, Maxime V, Ibrahim F, et al: Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174:1319-1326
45. Hamrahian AH, Oseni TS, Arafah BM: Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629-1638
46. Arafah BM: Hypothalamic pituitary adrenal function during critical illness: Limitations of current assessment methods. J Clin Endocrinol Metab 2006; 91:3725-3745